Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by HuntNGatheron Dec 21, 2012 3:06pm
130 Views
Post# 20762530

RE: RE: RE: RE: RE: Shareholder Power Against Cons

RE: RE: RE: RE: RE: Shareholder Power Against Cons

Well Mr Profit..... or should I say Mr Prophet.....

I tried to be nice and conciliatory.

You have a universal axe to grind that does not have any specific relevance to SCT.

Silly Me.  Thankfully there is an app for that.  55 others have used that button already.

I will ignore your blather from now on because you are a one trick pony and I grow tired of the trick.

 

HnG

Bullboard Posts